ADLS got hammered! looking to fill gap down the road. In at .201 this morning. One of its drugs needs more data with the FDA it is working expeditiously, to satisfy FDA's request for additional efficacy information. One stock to keep on radar.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.